Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund's Biogen Inc Holding Summary
As of 2023-09-30, Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund held - shares of Biogen Inc(BIIB), totaling N/A. This investment constitutes 0% of their stock portfolio, and Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund now holds 0% of the outstanding Biogen Inc(BIIB) stock.
The initial trade took place in 2019Q3. And since then Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund has made 3 purchases of BIIB, at an average price of $319.54, for a total of 3,413.00 shares. In addition, there have been 7 sales at an average price of $275.36 for 3,413.00 shares. Based on historical transaction data and BIIB's current price of $126.31, Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund's estimated gain on his BIIB holdings is $-150,782.31, reflecting a -13.83% gain to date.
Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund BIIB ($126.31) Holding Chart
Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund BIIB ($126.31) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
